All News

sarcoid2.jpg

Severe Cutaneous Sarcoid Treated with Tofacitinib

d Jack Cush, MD

Researchers from Yale have taken a novel approach and shown benefits when using tofacitinib in severe cutaneous sarcoidosis.

Read Article
pregnancy.sperm_.jpg

Best of 2018: The Safety of Paternal Exposure to DMARDs and Biologics

d Jack Cush, MD

Pregnancy and drug safety is a complex issue, often with limited information about maternal drug exposure on the offspring. Greater uncertainty exists when considering whether paternal exposure may also influence fetal outcomes.

Read Article
Nurse_0.jpg

Best of 2018: Advance Practice Clinicians Proliferating in Specialty Practices

d Jack Cush, MD

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.

Read Article
The Downside of social media for patients: 1. if substituted for in-person support, 2. Misinformation, 3. Financial exploitation, 4. Information overload, 5. Compromised privacy https://t.co/FtPUkZespC

Links:

Dr. John Cush RheumNow ( View Tweet)

Social Media Benefits for patients: 1. Promotes engagement and empowerment 2. Provides psychosocial support, 3. informational support, 4. improves MD-patient relationship, 5. linical trials and cancer research education https://t.co/FtPUkZespC

Links:

Dr. John Cush RheumNow ( View Tweet)

Eli Lilly has announced that FDA has granted Fast Track designation to baricitinib, to be studied for the treatment of systemic lupus erythematosus (SLE). This drug is NOT FDA approved for lupus https://t.co/vK7i6AoKab

Links:

Dr. John Cush RheumNow ( View Tweet)

Congratulations to Professor Iain McInnes - he is one of the Queen's New Year Honours in Scotland, as a Commander of the Order of the British Empire (CBE), for his services to medicine. https://t.co/15bIELJiEj

Links:

Dr. John Cush RheumNow ( View Tweet)

Full text review of psoriatic arthritis for NPs and PAs https://t.co/hlLKLAQ9ZX

Links:

Dr. John Cush RheumNow ( View Tweet)

Abbvie has submitted its new JAK inhibitor, upadacitinib, to the FDA and EMA for consideration in moderate to severe rheumatoid arthritis https://t.co/49GspIEeYN

Links:

Dr. John Cush RheumNow ( View Tweet)

Best wishes for a charmed 2019! My advice: 1. Just show up. 2. If you can, then you must do. 3. Live each day as if it twas your 1st day/last day/make or break day. 4. Teach

Dr. John Cush RheumNow ( View Tweet)

“Never turn down an opportunity and don’t be afraid to address your failures”. - NFL great, Michael Strathan

Dr. John Cush RheumNow ( View Tweet)

"I'm addicted to placebos. I'd give them up, but it wouldn't make any difference." - Steven Wright

Dr. John Cush RheumNow ( View Tweet)

Yet ~100 fellowship applicants did not match this year. Need creative ways to fund training programs including NP/PA. @RheumResearch has opportunities. https://t.co/acT1qew3pG

Links:

David Karp DrDavidKarp ( View Tweet)

More than half of older Americans have "basic" or "below basic" health literacy. How do you make health care decisions when you don't even understand what the doctor is saying? https://t.co/8b3nLT6wMi

Links:

NYT Health NYTHealth ( View Tweet)

Hearty congratulations to Prof Iain McInnes CBE for being recognised in the Queen’s New Year Honours for services to medicine! Well deserved recognition 🎉 https://t.co/gJFVjuJHEC

Links:

RACE GBN Racegbn ( View Tweet)

Check out the @ACRheum's comments about the Trump administration's proposed model to lower prices of drugs provided in clinics & infusion centers Though I was skeptical @ first, I'm grateful to the administration for listening to rheumatologists's ideas: https://t.co/vvjaeaF40I

Links:

Angus Worthing MD AngusWorthing ( View Tweet)

Reprint of "The interaction between environmental triggers and epigenetics in autoimmunity" #openaccess https://t.co/Kf189ViFSa https://t.co/FWfjy0QCrH

Links:

Elsevier Immunology ImmunologyNews ( View Tweet)
From @NYTOpinion: CBD is being touted as the latest miracle cure. Enthusiasts rave about its supposed anti-anxiety, anti-inflammatory, antidepressant and anti-everything-you-don’t like effects. But does it work? https://t.co/yDuzeEh49t

Links:

NYT Health NYTHealth ( View Tweet)

#ScienceHighlights2018: 2018 brought scientific advances in #Ebola, #HIV, #tuberculosis, #influenza, #eczema, #autoimmune diseases & many other areas: https://t.co/Zc2obI6Smj 🔬🧫🦠 https://t.co/d1FWdjam0R

Links:

NIAID News NIAIDNews ( View Tweet)
Nice update and review of Vaccination issues in Rheumatology - featuring insights from Drs. Len Calabrese, Steve Lindsey, Jeff Curtis, Kevin Winthrop & Betsy Kirchner ANP. https://t.co/xDTiO9xpHS

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×